Get the Stockscreener App
5.13
1.35%
-0.07
Syros Pharmaceuticals Inc. Stock (SYRS) Forecast
The Syros Pharmaceuticals Inc. (SYRS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.87, representing a +189.81% increase from the current price of $5.13. The highest analyst price target is $28.97, and the lowest is $0.7672.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SYRS Price Target
Average 29.42
(+473.45% Upside)
Is Syros Pharmaceuticals Inc. (SYRS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.46 | Neutral |
| STOCH(9,6) | 64.67 | Neutral |
| STOCHRSI(14) | 64.84 | Neutral |
| MACD(12,26) | -0.1454 | Buy |
| ADX(14) | 13.59 | Neutral |
| William %R | -46.32 | Neutral |
| CCI(14) | 9.9622 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.189
Sell
|
5.209
Sell
|
| MA20 |
5.2005
Sell
|
5.2723
Sell
|
| MA50 |
5.8933
Sell
|
5.6377
Sell
|
| MA100 |
6.2993
Sell
|
5.615
Sell
|
| MA200 |
4.8131
Buy
|
5.1108
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, SYRS could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on SYRS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.46 indicates that SYRS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 64.67 indicates that SYRS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.84 indicates that SYRS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.59 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 9.9622 indicates that SYRS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term SYRS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Syros Pharmaceuticals Inc. financial reports and earnings history, Syros Pharmaceuticals Inc. (SYRS) stock could reach $66.88 by 2030, $52.15 by 2040 and $145.24 by 2050. See the projected annual prices until 2050 of the Syros Pharmaceuticals Inc. stock below:
- Syros Pharmaceuticals Inc. (SYRS) is expected to reach an average price of $18.66 in 2035, with a high prediction of $20.56 and a low estimate of $18.76. This indicates an $263.67% rise from the last recorded price of $5.13.
- Syros Pharmaceuticals Inc. (SYRS) stock is projected to chart a bullish course in 2040, with an average price target of $49.80, representing an $870.77% surge from its current level. The forecast ranges from a conservative $50.31 to a sky-high $52.15.
- Our analysts predict Syros Pharmaceuticals Inc. (SYRS) to jump 1,672% by 2045, soaring from $91.69 to an average price of $90.90, potentially reaching $91.91. While $91.69 is the low estimate, the potential upside is significant.
- Syros Pharmaceuticals Inc. (SYRS) stock is expected to climb by 2050, reaching an average of $143.98, a $2,707% jump from its current level. However, a wide range of estimates exists, with high and low targets of $145.24 and $145.28, respectively, highlighting the market's uncertainty.
Syros Pharmaceuticals Inc. Stock (SYRS) Year by Year Forecast
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2024
Our forecast for SYRS stock price in 2024 now indicates an average price target of $29.30 with a high forecast of $58.21 and a low forecast of $0.3939. The average prediction reflects an increase of +471.22% from the last recorded price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $28.77 | $0.7672 | $28.97 | +460.76% |
| July, 2024 | $14.49 | $6.6827 | $30.67 | +182.39% |
| August, 2024 | $46.00 | $10.39 | $55.15 | +796.73% |
| September, 2024 | $48.72 | $29.81 | $58.21 | +849.66% |
| October, 2024 | $7.687 | $5.637 | $52.82 | +49.84% |
| November, 2024 | $6.9475 | $7.7514 | $9.0408 | +35.43% |
| December, 2024 | $12.23 | $9.9436 | $8.2398 | +138.44% |
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2025
Syros Pharmaceuticals Inc. Stock (SYRS) is expected to reach an average price of $48.82 in 2025, with a high prediction of $97.03 and a low estimate of $0.6223. This indicates an +851.75% rise from the last recorded price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.59 | $7.6796 | $27.48 | +145.37% |
| February, 2025 | $13.85 | $10.59 | $37.30 | +170.04% |
| March, 2025 | $3.3184 | $2.1094 | $24.71 | -35.31% |
| April, 2025 | $4.2378 | $0.6223 | $9.4262 | -17.39% |
| May, 2025 | $33.85 | $4.1583 | $34.75 | +559.91% |
| June, 2025 | $41.37 | $25.86 | $54.67 | +706.41% |
| July, 2025 | $47.29 | $33.19 | $52.09 | +821.80% |
| August, 2025 | $63.80 | $45.54 | $74.60 | +1,144% |
| September, 2025 | $71.72 | $42.67 | $76.81 | +1,298% |
| October, 2025 | $49.89 | $47.34 | $97.03 | +872.49% |
| November, 2025 | $39.95 | $36.65 | $58.05 | +678.83% |
| December, 2025 | $19.27 | $16.57 | $54.07 | +275.70% |
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2026
The predicted value for Syros Pharmaceuticals Inc. (SYRS) in 2026 is set at an average of $56.33. Estimates vary from a peak of $110.91 to a trough of $1.7481, indicating an +998.01% surge from the present price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $34.89 | $18.78 | $49.48 | +580.10% |
| February, 2026 | $76.40 | $27.35 | $79.70 | +1,389% |
| March, 2026 | $96.02 | $54.52 | $110.91 | +1,772% |
| April, 2026 | $69.94 | $57.34 | $110.12 | +1,263% |
| May, 2026 | $48.66 | $23.45 | $72.34 | +848.44% |
| June, 2026 | $22.97 | $21.67 | $52.06 | +347.77% |
| July, 2026 | $10.89 | $6.1909 | $27.02 | +112.28% |
| August, 2026 | $18.71 | $9.0938 | $29.40 | +264.63% |
| September, 2026 | $14.02 | $9.7248 | $19.71 | +173.39% |
| October, 2026 | $8.2404 | $4.6365 | $14.83 | +60.63% |
| November, 2026 | $15.16 | $1.7481 | $15.56 | +195.44% |
| December, 2026 | $8.0753 | $6.1753 | $18.96 | +57.41% |
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Syros Pharmaceuticals Inc. (SYRS) is $38.44, with a high forecast of $76.51 and a low forecast of $0.3704. This indicates an +649.37% increase from the last price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.2908 | $5.5908 | $11.79 | +22.63% |
| February, 2027 | $3.6063 | $3.4063 | $11.10 | -29.70% |
| March, 2027 | $1.0257 | $0.5179 | $8.9218 | -80.01% |
| April, 2027 | $6.4588 | $0.3704 | $4.9373 | +25.90% |
| May, 2027 | $15.24 | $11.65 | $12.15 | +197.14% |
| June, 2027 | $20.52 | $17.09 | $18.33 | +300.08% |
| July, 2027 | $18.81 | $20.21 | $19.06 | +266.63% |
| August, 2027 | $17.79 | $19.80 | $18.80 | +246.84% |
| September, 2027 | $21.65 | $20.96 | $76.51 | +322.00% |
| October, 2027 | $17.86 | $19.06 | $20.07 | +248.11% |
| November, 2027 | $18.48 | $18.35 | $17.72 | +260.28% |
| December, 2027 | $16.67 | $17.72 | $17.65 | +224.99% |
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2028
In 2028, Syros Pharmaceuticals Inc. (SYRS) is projected to reach an average price of $15.93, with a high projection of $19.05 and a low estimate of $12.81. This indicates an +210.52% rise from the last price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.59 | $17.74 | $17.12 | +242.93% |
| February, 2028 | $18.15 | $18.40 | $18.08 | +253.84% |
| March, 2028 | $18.55 | $18.49 | $19.05 | +261.65% |
| April, 2028 | $18.62 | $18.81 | $18.92 | +262.91% |
| May, 2028 | $18.52 | $18.51 | $18.38 | +260.97% |
| June, 2028 | $16.46 | $16.62 | $17.93 | +220.90% |
| July, 2028 | $15.86 | $15.50 | $16.04 | +209.10% |
| August, 2028 | $15.96 | $15.74 | $15.74 | +211.06% |
| September, 2028 | $15.77 | $15.85 | $15.71 | +207.34% |
| October, 2028 | $14.31 | $14.51 | $15.22 | +178.87% |
| November, 2028 | $12.71 | $12.85 | $13.65 | +147.70% |
| December, 2028 | $12.47 | $12.81 | $12.51 | +143.11% |
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2029
The 2029 price forecast for Syros Pharmaceuticals Inc. Stock (SYRS) is $29.58 on average, with a high prediction of $59.12 and a low estimate of $0.0477. This represents an +476.68% increase from the previous price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.62 | $10.83 | $12.28 | +107.06% |
| February, 2029 | $9.7864 | $9.7864 | $10.40 | +90.77% |
| March, 2029 | $9.0409 | $9.2609 | $9.5425 | +76.24% |
| April, 2029 | $9.5654 | $8.705 | $9.0454 | +86.46% |
| May, 2029 | $8.336 | $8.666 | $9.5315 | +62.50% |
| June, 2029 | $7.6605 | $7.8005 | $7.7483 | +49.33% |
| July, 2029 | $1.715 | $3.305 | $5.2166 | -66.57% |
| August, 2029 | $1.3456 | $1.6756 | $1.5433 | -73.77% |
| September, 2029 | $0.4101 | $0.8501 | $0.5817 | -92.01% |
| October, 2029 | $0.3807 | $0.0477 | $0.8416 | -92.58% |
| November, 2029 | $1.2952 | $1.2968 | $0.8929 | -74.75% |
| December, 2029 | $59.52 | $0.0565 | $59.12 | +1,060% |
Syros Pharmaceuticals Inc. Stock (SYRS) Price Forecast for 2030
Syros Pharmaceuticals Inc. Stock (SYRS) is expected to reach an average price of $40.36 in 2030, with a high forecast of $67.16 and a low forecast of $13.56. This signifies an +686.76% surge from the last price of $5.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $72.38 | $63.40 | $66.88 | +1,311% |
| February, 2030 | $38.75 | $45.15 | $56.27 | +655.36% |
| March, 2030 | $43.52 | $51.92 | $49.43 | +748.33% |
| April, 2030 | $14.79 | $17.45 | $29.21 | +188.27% |
| May, 2030 | $16.15 | $13.56 | $15.95 | +214.80% |
| June, 2030 | $65.72 | $36.64 | $50.62 | +1,181% |
| July, 2030 | $71.03 | $66.90 | $66.88 | +1,285% |
| August, 2030 | $44.45 | $70.15 | $67.16 | +766.44% |
| September, 2030 | $35.62 | $46.42 | $43.33 | +594.30% |
| October, 2030 | $32.63 | $35.61 | $35.69 | +536.04% |
| November, 2030 | $64.45 | $41.42 | $46.76 | +1,156% |
| December, 2030 | $47.92 | $58.33 | $48.74 | +834.05% |
1.62%
0.15%
Cap:
|
Volume (24h):